These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 30807896

  • 1. Design, synthesis and evaluation of d-amino acid-containing peptidomimetics targeting the polo-box domain of polo-like kinase 1.
    Li Z, Zhang Z, Chen Y, Tang S, Lin T, Huang J, Li B, Jiang C.
    Bioorg Chem; 2019 Apr; 85():534-540. PubMed ID: 30807896
    [Abstract] [Full Text] [Related]

  • 2. Identification of novel peptidomimetics targeting the polo-box domain of polo-like kinase 1.
    Li Z, Zhang Z, Sun H, Xu L, Jiang C.
    Bioorg Chem; 2019 Oct; 91():103148. PubMed ID: 31376784
    [Abstract] [Full Text] [Related]

  • 3. Identification of novel and selective non-peptide inhibitors targeting the polo-box domain of polo-like kinase 1.
    Chen Y, Li Z, Liu Y, Lin T, Sun H, Yang D, Jiang C.
    Bioorg Chem; 2018 Dec; 81():278-288. PubMed ID: 30170276
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors.
    Lin TY, Min HP, Jiang C, Niu MM, Yan F, Xu LL, Di B.
    Bioorg Med Chem; 2018 Jul 23; 26(12):3429-3437. PubMed ID: 29807699
    [Abstract] [Full Text] [Related]

  • 5. Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain.
    Chen Y, Zhang J, Li D, Jiang J, Wang Y, Si S.
    Oncotarget; 2017 Jan 03; 8(1):1234-1246. PubMed ID: 27902479
    [Abstract] [Full Text] [Related]

  • 6. Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1.
    Ryu S, Park JE, Ham YJ, Lim DC, Kwiatkowski NP, Kim DH, Bhunia D, Kim ND, Yaffe MB, Son W, Kim N, Choi TI, Swain P, Kim CH, Lee JY, Gray NS, Lee KS, Sim T.
    J Med Chem; 2022 Feb 10; 65(3):1915-1932. PubMed ID: 35029981
    [Abstract] [Full Text] [Related]

  • 7. Design and synthesis of a cell-permeable, drug-like small molecule inhibitor targeting the polo-box domain of polo-like kinase 1.
    Srinivasrao G, Park JE, Kim S, Ahn M, Cheong C, Nam KY, Gunasekaran P, Hwang E, Kim NH, Shin SY, Lee KS, Ryu E, Bang JK.
    PLoS One; 2014 Feb 10; 9(9):e107432. PubMed ID: 25211362
    [Abstract] [Full Text] [Related]

  • 8. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1.
    Ahn M, Han YH, Park JE, Kim S, Lee WC, Lee SJ, Gunasekaran P, Cheong C, Shin SY, Kim HY, Ryu EK, Murugan RN, Kim NH, Bang JK.
    J Med Chem; 2015 Jan 08; 58(1):294-304. PubMed ID: 25347203
    [Abstract] [Full Text] [Related]

  • 9. Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain.
    Shin SB, Woo SU, Yim H.
    J Cell Physiol; 2015 Dec 08; 230(12):3057-67. PubMed ID: 25975351
    [Abstract] [Full Text] [Related]

  • 10. Modulation of the Allosteric Communication between the Polo-Box Domain and the Catalytic Domain in Plk1 by Small Compounds.
    Raab M, Sanhaji M, Pietsch L, Béquignon I, Herbrand AK, Süß E, Gande SL, Caspar B, Kudlinzki D, Saxena K, Sreeramulu S, Schwalbe H, Strebhardt K, Biondi RM.
    ACS Chem Biol; 2018 Aug 17; 13(8):1921-1931. PubMed ID: 29927572
    [Abstract] [Full Text] [Related]

  • 11. Identification of acylthiourea derivatives as potent Plk1 PBD inhibitors.
    Yun T, Qin T, Liu Y, Lai L.
    Eur J Med Chem; 2016 Nov 29; 124():229-236. PubMed ID: 27592392
    [Abstract] [Full Text] [Related]

  • 12. Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.
    Zhao XZ, Hymel D, Burke TR.
    Bioorg Med Chem; 2017 Oct 01; 25(19):5041-5049. PubMed ID: 28285924
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis, and evaluation of non-ATP-competitive small-molecule Polo-like kinase 1 (Plk1) inhibitors.
    Chen DX, Huang J, Liu M, Xu YG, Jiang C.
    Arch Pharm (Weinheim); 2015 Jan 01; 348(1):2-9. PubMed ID: 25430493
    [Abstract] [Full Text] [Related]

  • 14. Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.
    Shan HM, Shi Y, Quan J.
    ChemMedChem; 2015 Jan 01; 10(1):158-63. PubMed ID: 25196850
    [Abstract] [Full Text] [Related]

  • 15. Development of Bifunctional Inhibitors of Polo-Like Kinase 1 with Low-Nanomolar Activities Against the Polo-Box Domain.
    Scharow A, Knappe D, Reindl W, Hoffmann R, Berg T.
    Chembiochem; 2016 Apr 15; 17(8):759-67. PubMed ID: 26634982
    [Abstract] [Full Text] [Related]

  • 16. Designed inhibitor for nuclear localization signal of polo-like kinase 1 induces mitotic arrest.
    Chen F, Zhuo X, Qin T, Guo X, Zhang C, Lai L.
    Chem Biol Drug Des; 2017 May 15; 89(5):732-740. PubMed ID: 27882722
    [Abstract] [Full Text] [Related]

  • 17. Identification of nitroimidazole-oxime derivatives targeting the polo-box domain of polo-like kinase 1.
    Sun J, Liu HY, Xu RF, Zhu HL.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6581-6588. PubMed ID: 29100732
    [Abstract] [Full Text] [Related]

  • 18. Structure-Based Virtual Screening and Biological Evaluation of Peptide Inhibitors for Polo-Box Domain.
    Yan F, Liu G, Chen T, Fu X, Niu MM.
    Molecules; 2019 Dec 27; 25(1):. PubMed ID: 31892137
    [Abstract] [Full Text] [Related]

  • 19. Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compounds.
    Abdelfatah S, Fleischer E, Klinger A, Wong VKW, Efferth T.
    Invest New Drugs; 2020 Feb 27; 38(1):1-9. PubMed ID: 30877426
    [Abstract] [Full Text] [Related]

  • 20. Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors.
    Zhao XZ, Tsuji K, Hymel D, Burke TR.
    Molecules; 2019 Apr 16; 24(8):. PubMed ID: 31014020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.